Answers are grounded in this paper and cite their sources.
OBJECTIVE: To determine the frequency of occult prostate cancer on endorectal MRI performed with high-level technique and interpretation. METHODS: We identified 76 men with biopsy-proven prostate cancer recruited into a prospective study of endorectal multiparametric 3T MRI before radical prostatectomy. The protocol included small field-of-view T2-weighted, high B-value diffusion-weighted, and high-temporal-resolution dynamic contrast-enhanced images. Studies were retrospectively and independently interpreted by 2 experienced readers and rated as positive or negative for prostate cancer, based on the presence or absence of PI-RADS version 2.1 category 3 to 5 lesions, respectively. A multidisciplinary panel reviewed MRI and whole-mount histopathology findings for concordance. RESULTS: A dominant tumor was identified in all patients at pathology; 1 was grade group 1, 44 were grade group 2, and 31 were grade group 3 or above. At MRI, reader 1 and 2 correctly identified the dominant tumor in 71 and 72 of 76 subjects, respectively. Both readers missed grade group 2 tumors in 2 patients. Reader 1 missed 2 other grade group 2 tumors and 1 grade group 4 tumor, while reader 2 missed 2 other grade group 2 tumors. CONCLUSIONS: Only 5.3% to 6.7% of dominant prostate cancers are occult at endorectal multiparametric MRI performed with advanced technique and interpretation, and most missed cancers are lower grade, suggesting many men with a negative endorectal MRI could be managed with surveillance rather than systematic biopsy.
No takes yet. Share an insight, caveat, or question.
Coakley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: